Structure
| TCI Product No. : | O0363 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Status : |
Status at 03:00 a.m. on Mar 11, 2010 * Items available from stock in Japan will be delivered in 10 business days |
||||||||||
| Purity / Analysis Method : | >98.0%(LC)(N) | ||||||||||
| Storage : | |||||||||||
| M.F. / M.W. : | C15H12N2O2=252.27 | ||||||||||
| CAS Number : | 28721-07-5 | ||||||||||
| Related CAS Number : | |||||||||||
| MDL Number : | MFCD00865307 | ||||||||||
SynthesisA new synthesis of oxcarbazepine using a Friedel–Crafts cyclization strategy Clinical evaluation in treatment of epilepsyA double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy Hyponatremic effectsOxcarbazepine-induced hyponatremia, a cross-sectional study |
| Merck Index(14) : | 6929 |
|---|---|
| RTECS# : | HN8445000 |
| Related Categories : |
|---|